ABSTRACT
INTRODUCTION
Temporal lobe epilepsies (TLEs) comprise a heterogeneous group of disorders sharing the same topographical seizure onset. TLE with hippocampal sclerosis is the most common type of epilepsy in adults. In one third of the patients seizures cannot be controlled by pharmacological therapies and may require further surgical approaches. Therefore, it is necessary to understand the molecular mechanisms of this devastating disease.
Neuronal degeneration is one of the hallmarks of mesial TLE (MTLE). A preferential neuron loss is characteristic in the CA1, CA3 and the hilus regions of the hippocampus. Besides, extra-hippocampal neuron loss has also been observed in MTLE in the entorhinal cortex, pyriform cortex and amygdala. However, it is not clear whether neuronal loss is the cause or the consequence of repetitive seizures (4, 11) . Another important finding in MTLE with hippocampal sclerosis (MTLE-HS) is chronic astroglial activation which results in sclerosis by increasing inflammatory cytokine production and thus potentiating excessive synaptic activity and inducing a "travelling effect" as activated astrocytes migrate to the epileptic focus (2, 13, 27) . During epileptogenesis, aberrant synaptic plasticity and mossy fiber sprouting have been assumed as the main reason of epileptic focus formation. Mossy fiber sprouting is characterized by dentate granule cell axons forming synapses with cells in the granular layer and inner molecular layer rather than in the CA3 region of the hippocampus (33) . Although the environmental changes deriving from seizures that drive sprouting are yet unclear, gliosis, release of cytokines, growth factors and adhesion molecules from activated astrocytes and microglia may have crucial role (42) . According to Pitkanen and Sutula, sprouting is progressive and is brought on by recurrent seizures (29) . The recurrent excitation hypothesis is supported by the fact that mossy fibers are glutamatergic axons and by evidence of excitatory circuit formation within the inner molecular layer (33) . On the contrary, it is believed that mossy fiber sprouting serves to reform inhibitory circuits that are lost during the initial damage to neurons where mossy fibers synapse primarily on inhibitory inter-neurons (11) . Besides, it has been noted that mossy fiber sprouting occurs secondary to neuron loss (15) .
Recently, matrix metalloproteinases' (MMPs) are found to be a possible key factor in epilepsy. MMPs are a large family of zinc dependent proteinases that are considered major elements conducting the extracellular matrix (ECM) remodeling and have pivotal role in cancer invasion and metastasis (1, 34) . Many studies have identified that MMPs are associated with various central nervous system (CNS) pathologies including stroke, traumatic brain injury, cerebral arteriovenous malformation, influenza associated encephalopathy and in bacterial meningitis where it has been identified as a risk factor for developing neurological sequel (8, 22, 39) . Moreover, many studies have reported that MMP-9 has implication in synaptic plasticity, learning and memory (21, 25, 28, 36) . Also, MMP-2 has been implicated in dendritic remodeling (36), axonal sprouting (30) , synaptic plasticity, and learning in the hippocampus (5, 21).
The activity of MMPs is counterbalanced by their natural inhibitors, the tissue inhibitors of matrix metalloproteinase's (TIMPs). In recent studies a physiological role of MMP-9 and its tissue inhibitor, TIMP-1, has been postulated in neuronal plasticity as well as long term potentiation (16, 24) . Recently, Wilczysky and colleagues have reported MMP-9 is an essential molecule in pentylenetetrazole epileptogenesis and MMP-9 deficiency diminished aberrant synaptogenesis (41) . In relation to epilepsy it is suggested that MMP-9 cleaves ECM molecules in and around the synaptic cleft where this is thought to be a necessary step in the cascade of events leading to new synapse formation.
The studies mentioned above are all experimental and the role of MMPs in human epilepsy is still obscure. Therefore, the aim of this study was to determine the hippocampal and neocortical expressions of MMP-9 and MMP-2 and their natural tissue inhibitors TIMP-1 and TIMP-2 in human MTLE-HS by using immunohistochemical methods. Here, we report the preliminary results of this study.
MATERIAL and METHODS

Patient Selection
Patients with mesial temporal lobe epilepsy associated with hippocampal sclerosis were enrolled in this study. Tissue samples of hippocampus and temporal neocortex were obtained from 3 (1 female, 2 male) patients with temporal lobe epilepsy with hippocampal sclerosis who had anterior temporal lobectomy surgery for recurrent medically resistant epileptic seizures. Informed consent for the use of tissue in research was obtained before surgery.
All of the patients' presurgical evaluations were consisted of detailed history and neurological examination, interictal and ictal electroencephalogram (EEG), neuropsychological testing and neuroimaging studies. All of the patients were refractory to multiple trials of antiepileptic drugs. Neuroimaging studies also revealed that none of them had a progressive disease in CNS. After surgical removal of the anterior temporal lobe, hippocampus and amygdala, conventional neuropathologic examination revealed mesial temporal sclerosis.
Tissue Processing
Adequate amount of the resected materials were immediately fixed in 10 % buffered in formalin for 24 h. Formalin-fixed tissue samples were embedded in paraffin and cut into 5 μm sections. 5µm thick serial sections were collected on poly-Llysine coated slides (Sigma-Aldrich, St. Louis, MO, USA) and incubated overnight at 56 o C.
Adequate amount of tissue samples were fixed with phosphate buffered (pH 7.4) 2.5% glutaraldehyde solution for trensmision electron microscopy.
Immunohistochemistry
For MMP-9, MMP-2, TIMP-1 and TIMP-2 immunohistochemistry, paraffin sections were deparaffinized and blocked for endogenous peroxidase activity with methanol containing 3% H 2 O 2 for 15 min. and for nonspecific binding with universal blocking reagent (BioGenex, San Ramon, CA, USA) for 10 min. at room temperature (37) . Anti-rabbit MMP-9 (Neomarkers cat#RB-1539P), MMP-2 (Neomarkers cat#RB-1588P), TIMP-1 (Neomarkers cat# RB-1531P), TIMP-2 (Neomarkers cat# RB-1489P) and anti-rabbit cleaved caspase-3 (Asp 175) (Cell Signaling #9661) antibody diluted in dilution buffer (1/5000, 1/400, 1/200, 1/400, 1/250, respectively) were applied for overnight at +4 0 C in a humidified chamber. For negative controls the primary antibodies were replaced by normal rabbit IgG serum (Vector Lab. Burlingame, CA, USA) at the same concentration. After several washes in PBS, sections were incubated with biotinylated goat anti-rabbit IgG secondary antibody (1/400 dilution Vector Lab. Burlingame, CA, USA) for 1h. followed by LSAB streptavidin-peroxidase complex (Dako, Carpinteria, CA, USA) incubation for 45 min. and were rinsed with PBS. Antibody complexes were visualized by incubation with diaminobenzidine (DAB) chromogen (BioGenex). Sections were counterstained with Mayer's hematoxylin (Dako), dehydrated, mounted and examined by a Zeiss-Axioplan (Oberkochen, Germany) microscope.
Transmission Electron Microscopy (TEM) Analysis
Tissue samples were fixed with phosphate buffered (pH 7.4) 2.5% glutaraldehyde solution followed by 1 hour at 4°C with 2% osmium tetroxide. Samples were dehydrated through a gradually increasing series of ethanol and embedded in Araldite resin (Araldite CY 212, 91 ml + dodecenyl succinic anhydride (DDSA) 84 ml + N,N-dimethylbenzylamine (BDMA) 3.5 ml, TAAB Company, England). Semi-thin (1 μm) and thin (40-60 nm.) sections were cut using diamond knives on a Leica ultramicrotome (Leica ultracut, UCT, Leica MZ6, England). Ultra-thin sections were collected on copper grids. In thin sections, double-contrast staining was applied with uranyl acetate (100 ml methanol and 5 g uranyl acetate) and Reynold's lead nitrate solution (1.76 g sodium citrate, 1.33 g lead nitrate, 50 ml distilled water and 8 ml 1N.NaOH). Thin sections were examined using a LEO 906 transmission electron microscope (Leo 906E, Zeiss, Germany).
RESULTS
MMP-9
Despite the cytoarchitectural damage, the neuronal expression of MMP-9 was more significant than MMP-2, particularly on mossy fibers. Both neurons and glial cells were labeled by the MMP-9 in CA1 and CA2 hippocampal subfields. Likewise, strong immunoreactivity for MMP-9 was seen in the granular cell layer of the dentate gyrus ( Figure 1A, MMP-9 ). In the temporal neocortex the cytoplasmic immunoreactivity for MMP-9 was so strong enabling to visualise the dendritic and axonal projections ( Figures 1E, F) .
MMP-2
The neurons in the CA1 ( Figure 1B , MMP-2) and CA2 ( Figure 1C , MMP-2) regions showed strong cytoplasmic immunoreactivity for MMP-2, however there was mild immunoreaction in CA3 neurons due to the damaged cytoarchitecture ( Figure 1D , MMP-2). In the neocortex, pyramidal neurons showed strong cytoplasmic immunoreactivity, but the glial cells were not immunostained (Figures 1E, F, MMP-2). 
TEM Analysis
The TEM analysis of the hippocampus revealed that there was apparent ultra-structural damage on the pericarya and neuropil of some neurons. (Figures 3A, B) . There was an obvious damage in the mitochondria and the nuclear membrane was ondulated and fragmented in hippocampal neurons. Especially in some hippocampal neurons pericarya was invaded by dense structure in cytoplasm ( Figure 3B ).
By TEM, some of the sub-cellular components and synaptic connections of the neocortex showed a normal structural organization. But, some of the pyramidal neurons were clearly observed with euchromatic nucleus, including very active nucleoli and subcellular organelles (Figures 3C,D) . The necrotic pericarya were observed with an irregular shape and dense cytoplasm containing many vacuoles, and a definitive pycnotic nucleus with nucleoli. There was an obvious mitochondrial damage such as cristae degeneration and matrix loss in the cytoplasm of both hippocampal and neocortical neurons (Figures 3A-D) . Moreover, in some areas there was a considerable number of normal appearing myelin sheaths with axoplasm ( Figure 3D ). Moreover, TEM analysis compatible with the caspase-3 immunostaining and also reflected the immune results.
DISCUSSION
Recent studies have linked MMPs to various CNS disorders including multiple sclerosis, Alzheimer's disease, malignant glioma, Parkinson's disease (24) . Also in epilepsy it is demonstrated that kindling progression persistently increased MMP-9 protein expression and activity in the mouse
TIMP-1
The CA1 neurons exhibited a weak immunoreactivity with TIMP-1 ( Figures 1A,B TIMP-1) . Moreover, the reaction was also weak in the mossy fibers in CA1 and CA2 subregions (Figures  1 B, C ; TIMP-1) while no immunoreaction was detected in the CA3 subregion of human hippocampus ( Figure 1D; TIMP-1) . However, the immunoreactivity was weak in the pyramidal neurons in the granular cell layer of the dentate gyrus ( Figure  1A ; TIMP-1). The neocortical reactivity for TIMP-1 in neurons was strong in parallel with MMP-9 (Figures 1E, F ; TIMP-1).
TIMP-2
There was a moderate cytoplasmic TIMP-2 immunolabelling localized in the CA1 hippocampal subregion neurons ( Figure  1B ; TIMP-2), and a strong mossy fibers immunolabelling were also observed in CA2 and CA3 hippocampal subregions 
Caspase-3
The antibody specific for activated caspase-3 selectively labeled the cytoplasm of cells that had a morphology consistent with apoptosis. Occasional nuclear staining was observed in neocortex. In CA subregions of the hippocampus, activated caspase-3-labelled cells were clearly detected (Figures 2 A-C) . kindling (9) . Besides, excessive levels of synaptic glutamate and persistent influx of Ca +2 through NMDA receptors are considered as major causes of epileptogenesis (7) . It has been reported that the expression and activity of MMP-9 depend on NMDA receptor activation and are associated with LTP development (21, 25) . Moreover, activation of NMDA receptors leads to MMP mediated modification of cell adhesion molecules and the development of dendritic spines (38) . Dendritic spine morphology and synaptic potentiation are dynamically modulated by ECM proteins and cell surface proteins with which they interact. It is suggested that ECM hippocampus, whereas acute convulsions had little effect on MMP-9 (23). In parallel with this, previous studies revealed that MMP-9 mRNA levels increased in response to neuronal depolarization in the rat hippocampus (32). Konopacki et al. also demonstrated that MMP-9 mRNA is transported to dendrites and synapses in the hippocampal dentate gyrus after seizure in kainic acid treated rats (19) .
There are convincing preclinical studies demonstrating that the expression and activity of MMP-9 is regulated by repetitive activation of NMDA receptors (23) . In fact, the inhibition of NMDA receptors prevented PTZ-induced convulsions and 
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In human epilepsy it is impossible to know what happens during the early stages of epileptogenesis and the findings of tissue based human epilepsy studies reflect the late stage of the epileptogenetic processes. This study is the first study in the medical literature demonstrating that MMP-9 expression in the hippocampus is increased in human MTLE-HS just as in the case of experimental epilepsy models. The preliminary results of our study showed that the neuronal expression of MMP-9 was significant, particularly on mossy fibers and the granular cell layer of the dentate gyrus as well as temporal neocortex. In experimental models it has been noted that once activated MMP-9 can be inhibited by TIMP-1. Together MMPs and TIMPs control the pericellular environment, including the turnover of ECM proteins, bioavailability of growth factors and cytokines and shedding of membrane receptors (34) . Moreover, TIMP-1 has an increased expression pattern following chemical SE and amygdala stimulation induced SE (3, 20, 26) . However, different from experimental studies, we found that TIMP-1 expression was weak in the hippocampus of the human MTLE-HS. The tissue material belongs to patients with medically refractory epilepsy that suggests that in the late stage of epilepsy TIMP-1 expression is diminished. According to these findings it can hypothesize that increased MMP-9 expression can be a result of a disinhibition process. Still, it is important to bear in mind that epileptogenesis in experimental models can be different than human epileptogenesis.
This study also showed severe neuronal loss both in the CA subregions of the hippocampus and temporal neocortex. This apoptotic cell loss was very severe in the CA subregions. Moreover, the electron microscopic analysis of the hippocampus revealed severe mitochondrial and nuclear damage. Mitochondrial dysfunction and oxidative stress are known to be the acute consequences of injuries inciting acquired epilepsies. Besides, there are evidences supporting the role of mitochondrial oxidative stress not merely as a consequence of seizures, but an active contributor to seizures and epileptogenesis (40) .
To our knowledge, our study is the first study showing that MMP-9 is associated with drug resistant MTLE -HS. However there are some limitations of our study. First of all, our data reflects only a small number of patients. Besides, the lack of comparisons with normal controls and other neurological diseases impeded us to make more clear suggestions. For all that because of the complexity to design tissue material based studies in human TLE, we think that our preliminary results will provide additional data in understanding the mechanism of epileptogenesis. Moreover, our results provide additional data about the mitochondrial dysfunction in human temporal lobe epilepsy. We hope that further studies will help understanding the mechanisms involved in seizureinduced cellular damage which is an essential basis for the development of rational neuroprotective strategies.
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The authors would like to thank Sibel Ozer for her excellent remodelling has an important role in synaptic plasticity. Wilczynsky et al. demonstrated that the sensitivity of PTZ epileptogenesis is decreased in MMP-9 knockout mice but is increased in a transgenic rat line overexpressing MMP-9 (41). In addition to this, electron microscopic studies revealed that MMP-9 is associated with hippocampal dendritic spines bearing excitatory synapses, where both the MMP-9 protein levels and enzymatic activity strongly increased upon seizures. Furthermore in the same study, seizure evoked pruning of dendritic spines and aberrant synaptogenesis were decreased in MMP-9 deficiency. It has also been suggested that cleaving the ECM molecules in and around the synaptic cleft by MMP-9 activity may be an essential step in the cascade of events leading to new synapse formation (41) .
In parallel to these findings Mizoguchi et al. provided additional data suggesting that mossy fiber sprouting induced by repeated PTZ treatment was reduced in MMP-9 null mice compared to wild type mice, suggesting that increased hippocampal MMP-9 activity is associated with sprouting of mossy fibers (23) . Besides, the previous studies have also revealed that several MMPs are acutely upregulated after status epilepticus (12) . These findings suggest that MMP-9 takes part in epileptogenesis both in acute and chronic processes.
The studies assessing the changes in MMP/TIMP ratio and MMP activity have shed some light on the developmental and pathological processes that occur in CNS (18, 31, 43) . In vivo experiments showed that TIMP-1 has implication in neuronal death and axonal sprouting in pathological situations as well as in the synaptic mechanisms underlying learning and memory in physiological conditions. In epilepsy, the upregulation of MMP inhibitors is also demonstrated in several studies. For instance, a broad spectrum MMP inhibitor can prevent kainate-induced neurodegeneration (6, 17) . The upregulation of the TIMPs may act as a compensatory mechanism to counterbalance the increased expression of MMPs. These data support the idea that the control of proteolysis is instrumental for pathological and physiological processes in the brain (17) . Overall these experimental evidences emphasize the role of MMP-9, as a key participant in neural death, aberrant synaptic plasticity and neuroinflammation that directly effects remodeling of synaptic linkage and that could represent a pharmacological target in epilepsy.
Although there is cumulative evidence indicating MMP-9 is a key factor in epileptogenesis in experimental models, its role in human epilepsy is still obscure. In a clinical study in children with prolonged febrile seizures and convulsive status epilepticus, it is reported that serum MMP-9 levels and the ratio of MMP-9 to TIMP-1 is elevated when compared to patients with simple partial seizures, West syndrome and controls (35) . In a Norwegian cohort designed to identify possible variants of the MMP-9 gene associated with TLE failed to show any polymorphisms in selected single nucleotide polymorphism of the human MMP-9 gene that are associated with TLE, MTLE-HS or TLE with febrile seizures (14) .
